REACTA BIOTECH LIMITED

Active Deeside

Research and experimental development on biotechnology

55 employees website.com
Research and experimental development on biotechnology
R

REACTA BIOTECH LIMITED

Research and experimental development on biotechnology

Founded 3 Jun 2013 Active Deeside, England 55 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 3 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 19 Jun 2025 Next due 23 Jun 2026 2 months remaining
Net assets £3M £1M 2024 year on year
Total assets £5M £2M 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Unit 2 Newtech Square Deeside Industrial Park Deeside CH5 2NT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for REACTA BIOTECH LIMITED (08553682), an active company based in Deeside, England. Incorporated 3 Jun 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£3.89M

Increased by £3.03M (+352%)

Net Assets

£3.08M

Increased by £1.09M (+55%)

Total Liabilities

£2.39M

Increased by £1.08M (+82%)

Turnover

N/A

Employees

55

Increased by 12 (+28%)

Debt Ratio

44%

Increased by 4 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2025Venture - Series Unknown

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 1,777,480 Shares £8.75m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Apr 202417,500£17.5£0.001
27 Jul 2023263,577£1.85m£7
27 Jul 2023356,905£500k£1.4
8 Jul 2021431,441£2.91m£6.74
8 Jul 20215,000£5£0.001

Officers

Officers

2 active 1 resigned
Status
Paul Andrew AbrahamsDirectorBritishEngland5520 Nov 2018Active
Simon Thelwall-jonesDirectorBritishUnited Kingdom5716 Oct 2023Active

Shareholders

Shareholders (58)

Dbw Investments (3) Limited
30.2%
598,125
Moulton Goodies Limited
27.4%
543,625

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased
Active
Notified 27 Jul 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Jon Moulton

British

Active
Notified 1 Jun 2018
Residence Guernsey
DOB October 1950
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Moulton Goodies Ltd

Ceased 1 Jun 2018

Ceased

Professor Ashley Arthur Woodcock

Ceased 21 Jan 2020

Ceased

Professor Elizabeth Naomi Clare Mills

Ceased 1 Dec 2019

Ceased

Group Structure

Group Structure

REACTA BIOTECH LIMITED Current Company
REACTA HEALTHCARE LTD united kingdom

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Mar 2026OfficersChange to director Mr Richard Nagle on 2026-03-13
11 Mar 2026OfficersAppointment of Mr Richard Nagle as director on 2026-03-10
24 Jun 2025OfficersTermination of Christopher Guy Weaver as director on 2025-06-24
19 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-09 with updates
18 Jun 2025Persons With Significant ControlDbw Investments (3) Limited notified as a person with significant control
13 Mar 2026 Officers

Change to director Mr Richard Nagle on 2026-03-13

11 Mar 2026 Officers

Appointment of Mr Richard Nagle as director on 2026-03-10

24 Jun 2025 Officers

Termination of Christopher Guy Weaver as director on 2025-06-24

19 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-09 with updates

18 Jun 2025 Persons With Significant Control

Dbw Investments (3) Limited notified as a person with significant control

Recent Activity

Latest Activity

Change to director Mr Richard Nagle on 2026-03-13

1 months ago on 13 Mar 2026

Appointment of Mr Richard Nagle as director on 2026-03-10

1 months ago on 11 Mar 2026

Termination of Christopher Guy Weaver as director on 2025-06-24

9 months ago on 24 Jun 2025

Confirmation statement made on 2025-06-09 with updates

10 months ago on 19 Jun 2025

Dbw Investments (3) Limited notified as a person with significant control

10 months ago on 18 Jun 2025